Rare Tumor
SWOG S1609
Official Title: Treatment with Ipilimumab and Nivolumab for Rare Cancers (DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors)
Study Purpose: To evaluate the effectiveness of treating rare cancers with two immunotherapy drugs: nivolumab and ipilimumab
Status:
Recruiting